Introduction
Supratentorial brain tumors in the pediatric and adult population are frequently associated with seizures. 1, 2 The frequency is higher among low grade tumors (60-85%) than among high grade tumors 20-40%. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Although treatment with initial anticonvulsants and surgery may be sufficient to prevent longterm epilepsy, 9,14,15 recurrent seizures occur 7, 16 often in the setting of tumor recurrence. 10, 17 Repeated seizures, refractory to medical management, has been reported in 14-20% of patients with primary brain tumors. 9, 14, 18 Surgery for epilepsy in the setting of current, or previously treated, low grade gliomas is a commonstrategy. 4, 11, [19] [20] [21] [22] When an epileptic focus is identified, surgery is considered in the setting of persistent epilepsy, 23, 24 with a rationale for even earlier identification of intractability when associated with a structural lesion. 19, 25 In appropriate candidates, surgical removal of epileptic foci is superior to medication alone 26 in providing seizure freedom.
Other options for therapy, such as additional medication, polytherapy, and vagus nerve stimulation, may be palliative but have a much lower seizure cure rate than surgery in patients with focal onset. 27 Surgical treatment of tumors for epilepsy may use electrophysiology to maximize seizure outcomes 28, 29 though this is not always employed. 16 Patients with high-grade tumors are less often operated on solely for control of their seizure disorder, perhaps because of the decreased length of expected survival. Certainly, such patients are uncommon. Malignant gliomas represented a minority of patients with temporal lobe tumors presenting with seizures to a large referral center 30 and appear nearly absent from major pediatric epilepsy series. 20 Additionally, the need for therapies, such as radiation therapy and chemotherapy, that increase the risk of diffuse cerebral insult could, in theory, make these patients poorer candidates for focal resection to ameliorate their seizures. We present four cases of patients who survived malignant primary brain tumors, in the pediatric setting, after aggressive surgery and adjuvant therapy, but developed medically intractable seizures. All underwent focal resection for their epilepsy, including the region of previous surgery. They responded well with seizure control and no new apparent neurological deficits. Seizure Epilepsy surgery is common in the face of benign brain tumors, but rarely for patients with a history of malignant brain tumors. Seizures are a common sequelae in survivors of malignant pediatric brain tumors. Medical management alone may not adequately treat epilepsy, including in this group. We report four cases of patients who previously underwent gross total resection, radiation therapy, and chemotherapy for successful treatment of malignant brain neoplasia, yet suffered from medically intractable seizures. All underwent surgery for treatment of epilepsy with extension of the original resection. Despite the aggressive primary treatment of the neoplasm, and the potential for diffuse cerebral insults, all benefited from focal surgical resection. Aggressive surgical management of intractable epilepsy can be considered in survivors of malignant brain tumors.
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outcomes were reported according to standard classification. 31 Medical records were reviewed according to a protocol approved by the Institutional Review Board of Seattle Children's Hospital.
Case 1
A 23-year old underwent gross total resection of a right frontal astrocytoma (grade III) after presenting at age 3 with developmental delay. He received whole brain radiation therapy and chemotherapy (lomustine, vincristine, hydroxyurea, procarbazine, cisplatin, cytosine arabinoside, dacarbazine, and methylprednisolone). He developed progressive seizures over the subsequent years and underwent a repeat surgery at age 9 for seizures and a concern for residual tumor. The seizure recurred, evolving to a frequency of twice daily, characterized by staring, left facial drop, interruption of speech and unusual behaviors such as repeated jumping, climbing, and going to the wash room.
He remained poorly controlled on therapeutic doses of carbamazepine, lamotrigine, and levetiracetam. His history was notable for hypopituitarism (anterior) related to radiation therapy. He had cognitive delay but was employed part-time, participated in Special Olympics, and was without focal neurologic findings. Neuropsychological testing demonstrated an IQ of 58 with global cognitive impairment. MRI revealed bilateral white matter changes along with encephalomalacia in the region of his original right frontal resection (Fig. 1A) . These white matter changes had been stable over several years and no evidence of recurrent tumor seen. A cavernous malformation was seen in the periventricular region posterior to the resection cavity.
Interictal EEG demonstrated frequent spike-wave discharges that were more over the right frontal lobe (Fig. 1B) . Ictal EEG and ictal SPECT also suggested a right frontal focus. He underwent repeat right frontal craniotomy for resection of epileptogenic focus, using electrocorticography 32 intraoperatively and computer-assisted navigation. The central sulcus was localized using median nerve evoked potentials 33 and cortical stimulation mapping. 34, 35 Electrocorticography showed interictal activity over the posterolateral and superomedial right frontal lobe, extending medial and posterior to the previous surgical site, but in front of motor cortex. The resection was carried out posterior to the previous surgical cavity and taken to the ventricle and then medially to the falx, completing a right superior frontal disconnection. Pathology revealed only a hypervascular scar with no neoplasm. Postoperatively, he had mild left arm weakness that recovered with a short course of outpatient occupational and physical therapy. He returned to work and had only rare seizures (Class II) for over 2 years until medication changes were associated with some recurrence (Class III) of events at a lower rate.
Case 2
This child presented with hydrocephalus and a large left posterior intraventricular tumor at 3 months of age. He underwent gross total resection of a choroids plexus carcinoma ( Fig. 2A) and was diagnosed, after resection of an adrenal cortical carcinoma, with Li-Fraumeni syndrome. He received chemotherapy (PBTC-012, cilengitide prior to etoposide but progressed to etoposide alone), after relapse several months later (initial chemotherapy had been declined), with response. He had no recurrence on serial MR imaging. However, he developed infantile spasms perioperatively and, at age 3 years, continued to have ten events per day despite therapeutic levels of topiramate, zonisamide, and clonazepam. Treatment with ACTH provided no benefit. Extensive herbal supplements including cod liver oil, Agaricus Blazei, Green Tea extract, vitamins D and K2, and enemas of shark cartilage were also employed by the family during his care. He had not developed expressive speech and understood few simple commands. He had a right hemiparesis and appeared to have a right sided neglect and/ or visual field deficit. EEG demonstrated multifocal spikes over the left hemisphere, especially the left central region (Fig. 2B) , with focal slowing over the left temporal, occipital and central regions. He had multiple epileptic spasms, without focal features, during a routine study.
Because of the lateralized nature of his EEG findings and the presence of lateralized neurological deficit, a hemispherectomy was recommended. He underwent disconnective hemispherotomy 36 with ventricular drainage. This procedure includes resection of the hippocampus and residual temporal lobe along with disconnection of remaining central and frontal cortex. Pathology showed only Fig. 3. (A) MRI scan of case 3 with a gross total resection of an atypical teratoid-rhabdoid tumor, again without evidence of recurrence. (B) Focal right frontal discharges that occurred nearly continuously (seen in leads marked by *) and evolved into seizures several times a day with behavioral effects. gliotic scars adjacent to the original resection. His motor examination was unchanged post-operatively and he developed expressive speech within 2 months of surgery. He had no further seizures and demonstrated accelerated language development, being seizure free (Class Ia), taking no anticonvulsant medication, at 4 years postoperative follow-up.
Case 3
A 6-year-old boy presented at 2 years of age with vomiting and was diagnosed with a right frontal atypical-teratoid rhabdoid tumor and underwent gross total resection (Fig. 3A) . He received focal radiation (5040 cGy) and chemotherapy (under CCG-99703, cisplatin, etoposide cyclophosphamide and vincristine followed by thiotepa and carboplatin and stem cell rescue). He developed seizures 2 years post operative, characterized by behavioral arrest with subsequent left arm flexion, hand dystonia, and throat clonus. Seizures lasted 20 s to 1 min with a rapid return to baseline. He failed multiple mediations and continued to have 10-40 seizures per day while treated with oxcarbazepine, lamotrigine, and levetiracetam. He had become less interactive with increasing seizure frequency and had slightly less use of his left hand. Interictal EEG demonstrated frequent stretches of subclinical continuous spike-wave activity (1-2 spikes/s) in the right frontal region (Fig. 3B ) along with right frontotemporal slowing. Seizure onset was seen electrically up to 2 s before the clinical event. The child underwent repeat right frontal craniotomy for lobectomy with intraoperative electrocorticography. The central sulcus was identified and confirmed using intraoperative somatosensory evoked potentials. Intraoperative electrocorticography was positive for diffuse spike wave activities through the lateral frontal lobe, orbitofrontal lobe and medial frontal cortex and these areas were disconnected or resected. The resection started 2-3 cm in front of the motor cortex and continued down to the lateral aspect of the ventricle, followed by disconnection of the medial frontal cortex. The disconnection was completed along the orbitalfrontal cortex. Post-resection corticography was free of epileptiform activity. Pathology was free of neoplasm, showing gliosis only. Post-operatively, he had mild worsening of his left hand dexterity which recovered fully within 6 weeks. He had no seizures and exhibited increasing alertness and communicativeness at 6 months follow-up and is now seizure free (Class Ia), on one anticonvulsant, 3-1/2 years post-operative.
Case 4
A 2-year-old girl presented at 5 months of age with seizures consisting of left arm jerking, increasing in frequency to several times a day. A right temporal lobe lesion was evident on CT and MRI (Fig. 4a) . She underwent craniotomy for gross total resection of anaplastic oligodendroglioma. She subsequently received chemotherapy (Temozolomide). A month later she developed infantile spasms that were poorly controlled by ACTH and ketogenic diet. Interictal EEG showed multifocal epileptiform discharges predominantly from right hemisphere. FDG-PET demonstrated diffuse hypometabolism on the right side with the spared right superior frontal area. MRI showed no change in the tumor, though pseudo-progression of the tumor occurred while on Vigabatrin and was reported. 37 Her seizures continued despite anticonvulsant medications including zonisamide, lamotrigine, and rufinamide. In addition to increasing frequency of seizures, the child presented with significant psychomotor delay (unable to sit or crawl and absence of expressive language) in addition to left hemiparesis. Two years after her initial surgery, she underwent a right functional hemispherectomy 36 with ventricular drainage including resection of the hippocampus and residual temporal lobe. Adjacent to the initial resection, pathology was consistent with recurrent/residual oligodendroglioma but with a much lower grade neoplasm than originally, with less cellularity, lower mitotic rate, and no endothelial proliferation. She has had only rare seizures on 1-year follow-up (3 breakthrough seizures at the time of viral illness when she was unable to take oral medication) and is taking only lamotrigine for seizures. She has had slow development, with gradual improvement of motor activity of the left extremities and socially interactive, but with no speech. Follow-up MRIs show no evidence of tumor.
Discussion
Surgical treatment for epilepsy associated with low-grade tumor is well established either at the time of first surgery or in the setting of intractable epilepsy in survivors. High grade brain tumors can be associated with epilepsy requiring aggressive medical management, 8, [38] [39] [40] yet surgical options in survivors is rarely reported, even in series focusing on brain tumors and epilepsy. [11] [12] [13] [14] 20 Unfortunately, seizure control appears to be incomplete in many of these patients. In addition to the impact of seizures on quality of life, 6 medication side effects are also a significant concern. 8, 41 Interestingly, in some series, patients with higher-grade tumors with long term epilepsy have shown better survival rates 11, 42 suggesting that seizure could be over-represented in survivors. Since one of the mechanisms hypothesized as associated with the epileptogenicity of low grade tumor is a slow creation of dysplastic or structural changes in adjacent brain tissue, this change takes time and the natural course of the low grade (or more favorable) tumor may make them more epileptogenic then high grade tumor. 4, 5, 8, 41, 43 Additionally, the longer survival of a less aggressive tumor would give more time for epilepsy to develop. In all of our patients, an aggressive approach to seizure control was taken. All had maximal medical therapy. In all cases, the video EEG was particularly helpful, capturing the epileptic events and localizing the interictal and ictal abnormality to a region (frontal lobe in two, one hemisphere in the other two) that was amenable to surgical resection without unacceptable or unanticipated morbidity. The non-dominant frontal lobe resection, kept in front of motor cortex, and the hemispherectomy in the child with spastic hemiplegia and visual field deficit were, in fact, well tolerated with all cases showing improved overall function associated with the resultant seizure control.
In other studies the occurrence of white matter changes presenting as changes in the T2 signal were associated with the development of intractable seizure. 22 This may be a helpful sign in surgical localization but, if focality was a correct assumption in our case 1 (as his current outcome would suggest), these T2 changes may over-represent the location of seizures, especially when distant from the original peritumoral region. Typically, post-operative seizures would give serious consideration to a possible tumor recurrence, 10, 17 however only case #4
had imaging or histopathological evidence of recurrence. None of the follow-up suggests recurrence thus it may be difficulty to assign epileptogenicity only to the original tumor, original surgery, chemotherapy, or diffuse radiation therapy, all of which could be associated with seizures. There was no evidence of underlying cortical dysplasia or other associated risk factor. Structural changes were seen, but likely of the type present after any prior therapy. In other series of reoperation for epilepsy, extension of the original surgery is often the most effective approach. 44 This approach was, in broad terms, successful in this series suggesting the original tumor insult was somehow relevant to the continued seizures. In contrast, adjuvant therapy would be thought to be less focal in its insult, thus a history of, for instance, radiation, would be a theoretical argument against a focal treatment such as epilepsy surgery, to treat seizures. This preliminary experience would argue for a search for focal epilepsy, even in such a situation.
Summary
These cases suggest a potential role for second surgery for seizure control in a select group of patients who develop medically intractable epilepsy 24 after surviving even high-grade primary brain lesion of childhood. Once long-term survival is suggested, surgical treatment of epilepsy should be a consideration for improving quality of life.
